Skip to content

Aehr Test Systems

US · AEHR #2391 by market cap Listed 1970
39.84 -8.10 -16.90%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Valuation each multiple against its own 5-year range

P/B ratio 8.41 In line with history 56th percentile
5-year average 9.45 · #25 of 30 in Semiconductor Equipment & Materials
P/E ratio 1,139.60 Expensive vs history 100th percentile
5-year average -14.54 · forward 50.23 · #25 of 25 in Semiconductor Equipment & Materials
P/S ratio 37.37 Expensive vs history 88th percentile
5-year average 16.65 · forward 11.39 · #29 of 31 in Semiconductor Equipment & Materials

Vs. peers Semiconductor Equipment & Materials

Company Market cap P/E (TTM) P/B Div yield
Aehr Test Systems (AEHR) 1.31B 796.80 5.88 0.00%
ASML Holding (ASML) 486.36B 33.02 20.10 0.70%
Applied Materials (AMAT) 240.17B 23.98 9.20 0.65%
Lam Research (LRCX) 228.94B 27.31 16.46 0.61%
KLA Corp (KLAC) 165.31B 31.80 25.34 0.66%
Teradyne (TER) 31.97B 23.54 8.67 0.25%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value53.64 Economic moatNone UncertaintyHigh

Trading 34.6% below Morningstar's fair value estimate.

Fair value

Aehr Test Systems is assigned a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 6% premium over our quantitative fair value estimate of $53.64 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.

The company's lack of profitability decreases our estimated valuation. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. Reflecting the firm's profitability is its earnings yield of 0.1%, which sits in the bottom 30% compared with global peers. The earnings generated by the company relative to its share price is concerning, which contributes to our view that shares are expensive.

The firm's valuation metrics are an additional cause for concern. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 12.7%, for example, ranks in the bottom 10% compared with global peers. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which further promotes our unfavorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is overvalued, this outperformance had a positive impact on our valuation estimate.

Economic moat

The company's quantitative economic moat rating of none suggests any excess returns could erode quickly as competition arrives. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-11-20 20:02:18 · For reference only, not investment advice and not tailored to your situation.

Aehr Test Systems discussion 0 comments

Add a comment